Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Proteomes|February 22, 2023
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR MutationsRei Noguchi, Akihiro Yoshimura, Junji Uchino, et al.
Future Oncology (London, England)|August 14, 2023
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study)Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 17, 2013
Pulmonary artery pseudoaneurysm caused by Streptococcus constellatusYoshitomo Morinaga, Katsunori Yanagihara, Hiroshi Gyotoku, et al.
Thoracic Cancer|November 5, 2023
TIM-3 expression induces resistance to PD-1 inhibitor in G-CSF-producing lung spindle cell carcinoma: A case reportFumiko Hayashi, Kazumasa Akagi, Hirokazu Taniguchi, et al.
Cancer Science|September 10, 2022
Pan-HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK-rearranged lung cancerHirokazu Taniguchi, Kazumasa Akagi, Yosuke Dotsu, et al.
Frontiers in Immunology|April 3, 2023
Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesotheliomaYasuhiro Umeyama, Hirokazu Taniguchi, Hiroshi Gyotoku, et al.
Chemotherapy|April 1, 2015
Phase I/II study of amrubicin and nedaplatin in patients with untreated, advanced, non-small cell lung cancerDaiki Ogawara, Yoichi Nakamura, Minoru Fukuda, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT studyTadaaki Yamada, Yasuhiro Goto, Hiroshi Tanaka, et al.
Thoracic Cancer|August 4, 2017
Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non-squamous non-small cell lung cancerShinnosuke Takemoto, Yoichi Nakamura, Minoru Fukuda, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2023
Second-line immunosuppressant administration for steroid-refractory immune-related adverse events in patients with lung cancerShinsuke Ogusu, Yuhei Harutani, Takehiro Tozuka, et al.
Pageof 4